Eli Lilly shares first human trial results for LOXO-435, a selective FGFR3 inhibitor for bladder cancer, showing 41% response ...
Parade on MSN22h
The #1 Early Breast Cancer Sign Most People MissIn the U.S., roughly one in eight women will be diagnosed with breast cancer in their lifetime. Breast cancer is the second ...
Related: Shannon Miller on Her Ovarian Cancer Diagnosis. The Early Ovarian Cancer Sign Most People Miss. According to experts ...
Patient perceptions about their treatment for muscle-invasive bladder cancer (MIBC) over the last decade. Dr. Chowdhury began his presentation by emphasizing that muscle-invasive bladder cancer (MIBC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback